Webhealth Logo

A Network Connecting Health Care Professionals
Connecting Millions Of MDs, Hospitals and Clinics

sign up

log in

Webhealth Logo
  • Home
  • HealthCare Pros
    • US Medical Doctor Directory
    • US Nurse Directory
    • Sign Up or Log In
  • HealthCare Directory
    • US Hospital Directory
    • US Clinic Directory
    • US Pharmacy Directory
    • US Lab Directory
  • Clinical Trials
    • Search by Name and Date
    • Clinical Trials By Letter
  • Videos
  • Solutions
  • About Us
  • Log-In
  • Sign-Up
Search for Clinical Trial Results

Search and View Clinical Trials by Topic

Amyloid Neuropathies - 25 Studies Found

Status Study
Available Study Name: Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR)
Condition: TTR-mediated Amyloidosis Amyloidosis, Hereditary
Date: 2016-10-18
Interventions: Drug: patisiran (ALN-TTR02) patisiran (ALN-TTR02) administered by intravenous (IV) infusion
Recruiting Study Name: A Safety and Tolerability Study of an Investigational Drug, ALN-TTRSC02, in Healthy Subjects
Condition: Transthyretin-mediated Amyloidosis (ATTR Amyloidosis)
Date: 2016-05-18
Interventions: Drug: ALN-TTRSC02 Ascending do
Recruiting Study Name: Carpal Tunnel Syndrome and Amyloid Cardiomyopathy
Condition: Amyloidosis Cardiomyopathy Transthyretin Amyloidosis
Date: 2016-04-20
Recruiting Study Name: Biomarker for Patients With Transthyretin-Related Familial Amyloidotic Polyneuropathy
Condition: Metabolic Diseases Amyloid Neuropathies
Date: 2016-01-13
Active, not recruiting Study Name: The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant
Condition: Transthyretin (TTR)-Mediated Amyloidosis Familial Amyloidotic Polyneuropathy (FAP)
Date: 2015-10-30
Interventions: Drug: Revusiran (ALN-TTRSC) 500mg Revusiran by subcutaneous (sc) injection
Enrolling by invitation Study Name: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)
Condition: Amyloidosis
Date: 2015-07-16
Interventions: Drug: Patisiran (ALN-TTR02) administered by intravenous (IV) infusion
Active, not recruiting Study Name: ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)
Condition: Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) Amyloidosis, Heredita
Date: 2014-12-12
Interventions: Drug: Revusiran (ALN-TTRSC) Drug: Sterile
Recruiting Study Name: Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement.
Condition: Heart Disease Aging Amyloidosis
Date: 2014-10-06
Interventions: Other: a basal LV septum biopsy During surgery, a basal LV septum biopsy will be collected for determina
Completed Study Name: Study of SOM0226 in Familial Amyloid Polyneuropathy
Condition: Familial Amyloid Polyneuropathy (FAP)
Date: 2014-07-09
Interventions: Drug: SOM0226 Oral
Enrolling by invitation Study Name: Open-Label Extension Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP)
Condition: FAP Familial Amyloid Polyneuropathy
Date: 2014-06-12
Interventions: Drug: IONIS-TTR Rx 300 mg IONIS-TTR Rx administered once weekly
Page 1 of 3
Next >>>

About

  • About Us
  • Terms of Use
  • Privacy Policy
  • Opt-Out & Information Removal
  • Contact Us
  • Advertising Privacy Policy

  • Webhealth Logo

Network Sites

  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • cancerHealthCenter
  • MentalHealthHelpCenter
  • OrthopedicsHealth
  • skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • painHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter

Partner Offers

  • All Offer
  • US
  • Canadian
  • Latin America
  • European
  • Asia Pacific
  • Other

Additional

  • Advertise With Us
  • Our Brands

WebHealth Network

WebHealth Network is the leading aggregator of health, fitness, and wellness news and information from across the Web. We provide our readers with the deepest access to health information from the most trusted health publishers.

We aim to be a one stop for all the info you need to stay healthy.

Our sources include hundreds of blogs, health sites, government sites, pharmaceutical manufacturers and much more. All the information provided is publicly available and is updated daily.

Not a Substitute for Medical Advise

WebHealth Network is designed for educational purposes only. The information provided is not a substitute for professional medical advise, diagnoses, or treatment. If you are experiencing problems with your health, it is recommended that you consult a medical professional, doctor, or other health care professional. Do not delay or avoid seekeing medical advise from a professional because of any information listed on WebHealth Network. The use of the information provided on the site is at your own risk.

Ongoing medical research may change or impact the information listed on WebHealth Network. No assurances are provided that the information listed will include the most updated developments.

If you are you are experiencing a medical emergency, please call your health care professional immediately.